Evercore ISI Group analyst Duane Pfennigwerth downgrades Delta Air Lines (NYSE:DAL) from Outperform to Neutral and lowers the price target from $50 to $40.
Reported Late Wednesday, Angion Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
Angion Biomedica Corp (NASDAQ:ANGN), a biopharmaceutical company that has focused on the discovery, development, and commercialization of novel small molecule therapeutics to address fibrotic diseases, announced that on
